Jefferies' Michael Yee expects Amgen's Horizon Therapeutics deal will go through despite FTC block
Downvote
Michael Yee, Jefferies managing director, joins 'Power Lunch' to discuss the FTC's move to block Amgen's $27.8 billion deal for Horizon Therapeutics.
This story from youtube.com was posted on 2023-05-16 by @airwise.